Ullevål PersonalityProject. A Randomized Controlled Trial of Intensive Daytreatment Followed by Outpatient Long-term Combined Treatment Compared With Eclectic Individual Therapy for Patients With Personality Disorders
Trial Snapshot
- Phase
- Not Applicable
- Sponsor
- Enrollment
- 120
- Locations
- 2
- Primary Endpoint
- Psychosocial functioning
Study Overview
Brief Summary
Ullevål PersonalityProject is a ranomized controlled trial of treatment of patients with personality disorder. It's main purpose is to test the effect of a long-term combined treatment program compared with eclectic individual therapy for patients with personality disorders.
The main study hypothesis is that long-term combined treatment is superior to eclectic individual therapy with respect to improvement in personality functioning, psychosocial functioning, symptoms, interpersonal problems, and self destructive behavior for poorly functioning patients with personality disorders.
Detailed Description
Ullevål PersonalityProject is a ranomized controlled trial of treatment of patients with personality disorder. It's main purpose is to test the effect of a long-term combined treatment program compared with eclectic individual therapy for poorly functioning patients with personality disorders.
The experiment treatment is guided by written treatment guidelines and comprises:
- 18 weeks intensive day treatment
- followed by long-term outpatient combined group psychotherapy and individual therapy for 4 and 2,5 years respectively.
The control treatment comprises:
- eclectic psychotherapy, here understood as psychotherapy according to the preference and regular practice of the therapist.
Study Design
- Study Type
- Interventional
- Allocation
- Randomized
- Intervention Model
- Parallel
- Primary Purpose
- Treatment
- Masking
- None
Eligibility Criteria
- Ages
- 20 Years to 50 Years (Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •Patients with personality disorders admitted to Department for personality psychiatry, Psychiatric division, Ullevål University Hospital
Exclusion Criteria
- •Schizotypal personality disorder, antisocial personaliy disorder, current alcohol or drug dependence, developmental disorders (e.g. Asperger), symptoms due to organic conditions, and lack of a permanent residence.
Outcomes
Primary Outcomes
Psychosocial functioning
Time Frame: The outcomes will be assessed after 8, 18, 36, and 72 months:
symptom distress
Time Frame: after 8, 18, 36 and 72 months
self esteem
Time Frame: after 8, 18, 36 and 72 months
interpersonal problems,
Time Frame: after 8, 18, 36 and 72 months
self destructive behavior,
Time Frame: after 8, 18, 36 and 72 months
personality pathology,
Time Frame: after 36 and 72 months
quality of life,
Time Frame: after 8, 18, 36 and 72 months
health care utilization after
Time Frame: after 8, 18, 36 and 72 months
Secondary Outcomes
- affect consciousness(after 36 months)
- reflective functioning(after 36 months)
